Evan Rachlin
Listed on 3 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Iambic Therapeutics, Inc. CIK 1997038 · CA
- Ascenta Capital Fund I, L.P. CIK 1957458 · DE
Filings (3)
-
Iambic Therapeutics, Inc.D · 2026-04-08 · CA · Biotechnology$50Mview →
-
Iambic Therapeutics, Inc.D · 2025-11-21 · CA · Biotechnology$125Mview →
-
Ascenta Capital Fund I, L.P.D · 2025-02-07 · DE · Pooled Investment Fund$350Mview →